DPIIT recognised startup Government of India
Startup India
Waruksha Laboratories Private Limited - pharma in Sanand, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹2.03 Cr
▼ 5% YoY
Net loss · FY 2025
₹31.82 Lakh
Net margin -15.7%
EBITDA · FY 2025
-₹16.95 Lakh
EBITDA margin -8.4%
Authorised capital
₹75 Lakh
Registered with MCA
Paid-up capital
₹58.5 Lakh
Issued & subscribed
Company age
8 yrs
Est. 2018
Directors on board
4
As per MCA filings
Active GSTINs
1
GST registered
About Waruksha Laboratories Private Limited
Data last updated:
Waruksha Laboratories Private Limited is a private limited company based in Sanand, Gujarat, India, recognised as a startup by DPIIT. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 24 September 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24110GJ2018PTC104366. Its GSTIN is 24AACCW2874P1ZR (Gujarat).
The company has an authorised share capital of ₹75 Lakh and a paid-up capital of ₹58.5 Lakh. It is led by directors including Shrikant Narayanrao Mogre and Rajesh Ramdas Warbhe.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Sanand, Gujarat.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.03 Cr, a decline of 5% compared to the previous year. For the same year it recorded a net loss of ₹31.82 Lakh (net margin -15.7%) and EBITDA of -₹16.95 Lakh (EBITDA margin -8.4%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 22% over five years.
Waruksha Laboratories Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0159043). For more details, the company can be reached via its website warukshalabs.com.
Company details
CIN U24110GJ2018PTC104366
Registration Number 104366
Incorporation Date 24 September 2018
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-GJ-01-0159043
Key People
Shrikant Narayanrao Mogre Director Rajesh Ramdas Warbhe Director Vidya Bhagwan Upadhayay Director Recognitions & Rankings of Waruksha Laboratories
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-GJ-01-0159043
Contact details
Waruksha Laboratories Private Limited's registered office is in Sanand, Gujarat. Its website is warukshalabs.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address7 8 9 Survey No. 138, Parishram Industrial Hub, Sanand, Gujarat, India – 382213
- IndustryPharma, API Manufacturers
To see the full contact details of Waruksha Laboratories Private Limited, buy the company report.
Comprehensive company report
Waruksha Laboratories Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Waruksha Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Waruksha Laboratories Private Limited, buy the company report.
Financials of Waruksha Laboratories Private Limited
FY 2025 filings availableWaruksha Laboratories Private Limited reported revenue of ₹2.03 Cr (down 5% YoY) for FY 2025.
Revenue · FY 2025
₹2.03 Cr ▼ 5%
Net loss · FY 2025
₹31.82 Lakh margin -15.7%
EBITDA · FY 2025
-₹16.95 Lakh margin -8.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 5%
3 years · compounded
▲ 9%
5 years · compounded
▲ 22%
EBITDA CAGR growth
1 year
▼ 109%
3 years · compounded
▼ 107%
5 years · compounded
▼ 69%
Revenue fell 5% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 22%. EBITDA fell 109% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹16.95 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹31.82 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -8.4% | ||||
| Net Profit Margin | -15.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Waruksha Laboratories Private Limited, buy the company report.
Board of directors of Waruksha Laboratories Private Limited
Waruksha Laboratories has 4 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shrikant Narayanrao Mogre | Director | 17 Oct 2020 | 6 Years 0 Months | Current |
| Rajesh Ramdas Warbhe | Director | 17 Oct 2020 | 6 Years 0 Months | Current |
| Vidya Bhagwan Upadhayay | Director | 27 Jun 2019 | 7 Years 4 Months | Current |
| Wajid Sajjad Jafri | Director | 24 Sep 2018 | 8 Years 1 Months | Current |
Peer comparison
Waruksha Laboratories Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Khushveer Life Sciences Private Limited | ₹2.14 Cr (FY 2025) | -8.0% | Thane, Maharashtra, India | |||
| Dikora Bulk Drug Private Limited | ₹2.1 Cr (FY 2025) | -48.0% | Bhusawal, Maharashtra, India | |||
| Omicron Pharma Private Limited | ₹2.1 Cr (FY 2025) | -3.0% | Surat, Gujarat, India | |||
| Waruksha Laboratories Private Limitedthis company | ₹2.03 Cr (FY 2025) | -₹31.82 Lakh | -15.7% | -5.0% | Sanand, Gujarat, India | |
| Vidgas Science & Technologies Private Limited | ₹1.99 Cr (FY 2025) | 218.0% | Hyderabad, Telangana, India | |||
| Richcore Enzymes Private Limited | ₹1.98 Cr (FY 2015) | 59.0% | Bangalore, Karnataka, India | |||
| Ratnagene Lifescience Private Limited | ₹1.98 Cr (FY 2023) | Ahmedabad, Gujarat, India |
To see the full peer comparison of Waruksha Laboratories Private Limited, buy the company report.
Auditor
Waruksha Laboratories Private Limited is audited by BHARGAV BHATT & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BHARGAV BHATT & ASSOCIATES | FY 2022 | 132641W |
Shareholding
The shareholding of Waruksha Laboratories Private Limited is on record for 4 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Waruksha Laboratories Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Waruksha Laboratories Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Waruksha Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Waruksha Laboratories has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AACCW2874P1ZR | Gujarat | Active | 30 Nov 2018 |
To see the full GST registrations and return filing status of Waruksha Laboratories Private Limited, buy the company report.
Recent activity
Waruksha Laboratories Private Limited has 10 board changes on record since 2018: 5 appointments and 5 cessations. The latest: Bhushan Sahasrabuddhey ceased to be Director on 02 Feb 2026.
Ceased
Bhushan Sahasrabuddhey ceased to be Director.
AGM
Waruksha Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Waruksha Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Ceased
Arul Ramakrishnan ceased to be Director.
Ceased
Rajesh Ramdas Warbhe ceased to be Additional Director.
Ceased
Shrikant Narayanrao Mogre ceased to be Additional Director.
Appointed
Rajesh Ramdas Warbhe was appointed as Director.
Appointed
Shrikant Narayanrao Mogre was appointed as Director.
Appointed
Vidya Bhagwan Upadhayay was appointed as Director.
Appointed
Bhushan Sahasrabuddhey was appointed as Director.
Ceased
Harsha Prabhavat ceased to be Director.
Appointed
Wajid Sajjad Jafri was appointed as Director.
1 earlier event is in the company report.
Frequently asked questions
Waruksha Laboratories is an active private limited company based in Sanand, Gujarat, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 24 September 2018 (8+ years old) and is registered under CIN U24110GJ2018PTC104366.
Waruksha Laboratories has 4 current directors:
- Shrikant Narayanrao Mogre - Director
- Rajesh Ramdas Warbhe - Director
- Vidya Bhagwan Upadhayay - Director
- Wajid Sajjad Jafri - Director
The latest financial statements of Waruksha Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Waruksha Laboratories is 24AACCW2874P1ZR, registered in Gujarat.
The CIN (Corporate Identification Number) of Waruksha Laboratories is U24110GJ2018PTC104366. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Waruksha Laboratories was incorporated on 24 September 2018, making it 8+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Waruksha Laboratories by revenue are Khushveer Life Sciences Private Limited, Dikora Bulk Drug Private Limited, Omicron Pharma Private Limited, Vidgas Science & Technologies Private Limited, Richcore Enzymes Private Limited and 1 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Bhushan Sahasrabuddhey ceased to be Director on 02 Feb 2026. Arul Ramakrishnan ceased to be Director on 30 Mar 2021. Rajesh Ramdas Warbhe ceased to be Additional Director on 31 Dec 2020. Waruksha Laboratories has 10 board changes on record in total.
Yes, Waruksha Laboratories is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Waruksha Laboratories is registered as a micro enterprise under Udyam registration (number: UDYAM-GJ-01-0159043).
Waruksha Laboratories can be reached through the website warukshalabs.com. Its registered office is in Sanand, Gujarat, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages